MDL | - |
---|---|
Molecular Weight | 581.71 |
Molecular Formula | C33H39N7O3 |
SMILES | CN1C(C2=CC=CC(CNC3=CC(C(C)(O)C)=NC4=C(C5=CC(C(N(C)[C@@H](C)CO)=O)=C(C=C5)C)C(C)=NN34)=C2)=NC=C1 |
PI4KIIIbeta-IN-11 is an inhibitor of PI4KIIIβ , with a mean pIC 50 value of at least 9.1. PI4KIIIβ plays a key role in diseases research of RNA viruses and Plasmodium falciparum [1] [2] .
PI4KIIIβ 9.1 (pIC 50 ) |
PI4KIIIβ may be a relevant target protein for inhibition of Hedgehog signaling, and regulates trafficking from the Golgi system to the plasma membrane
[1]
.
PI4KIIIbeta-IN-11 (compound 22) (0.5 μM; 0-45 min) shows metabolic stability in human microsomes, with the intrinsic clearance of 33.7 mL/min/g
[2]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
PI4KIIIbeta-IN-11 (compound 22) (1 mg/kg; i.v.; last over 1 h) displays a low spleen concentration in rats
[2]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | Male Wistar Han Rats [2] |
Dosage: | 1 mg/kg |
Administration: | Intravenous injection, formulated in 2% DMSO in Kleptose (aq, 10% w/v); over 1 hour; euthanised at 12 h |
Result: | Showed a low concentration in spleen of 5.54 ng/g. |
Room temperature in continental US; may vary elsewhere.
Please store the product under the recommended conditions in the Certificate of Analysis.